113 results
Page 4 of 6
8-K
EX-99.1
zxixk6gefpp9f3k
16 Feb 22
Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
7:39am
8-K
EX-1.1
7r89fprm4 g800m0
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
424B5
56ek 5nhkhd02g3gnwci
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
g97vvln8tr6
10 Dec 21
Prospectus supplement for primary offering
5:25pm
424B5
3t3u4t8t 3flq1c
10 Nov 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
8xsku
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
424B5
m7plq
9 Nov 21
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
k728bn
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am
8-K
i7hyr 7bhv4hhy9f
5 Apr 21
Departure of Directors or Certain Officers
4:49pm
8-K
EX-99.1
kyv kcnvqii
17 Dec 20
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
9:02am